ping an-乐鱼官方网站在线登陆入口

1. a new generation of proton pump inhibitors, the first generic drug marketed in china；
2.“stronger” - multi-targeted inhibition of four channels of the proton pump with strong acid inhibition；
3.“faster” - high pka value, fast onset of action and longer lasting acid suppression；
4.“safer” - the only ppi in the “non-enzymatic metabolic pathway”, with little individual variation in clinical use and few drug interactions.